A
Ashley Yacoubian
Researcher at University of Tennessee Health Science Center
Publications - 3
Citations - 205
Ashley Yacoubian is an academic researcher from University of Tennessee Health Science Center. The author has contributed to research in topics: Vaginal delivery & CA19-9. The author has an hindex of 3, co-authored 3 publications receiving 164 citations.
Papers
More filters
Journal ArticleDOI
MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer.
Sheema Khan,Mara C. Ebeling,Mohd Saif Zaman,Mohammed Sikander,Murali M. Yallapu,Neeraj Chauhan,Ashley Yacoubian,Stephen W. Behrman,Nadeem Zafar,Deepak Kumar,Paul A. Thompson,Meena Jaggi,Subhash C. Chauhan +12 more
TL;DR: It is demonstrated that miR-145 targets 3′ untranslated region of M UC13 and thus downregulates MUC13 protein expression in cells and thus inhibits cell proliferation, invasion and enhances gemcitabine sensitivity.
Journal ArticleDOI
Effect of Single-Treatment, Surface-Cooled Radiofrequency Therapy on Vaginal Laxity and Female Sexual Function: The VIVEVE I Randomized Controlled Trial.
Michael Krychman,Christopher G. Rowan,Bruce B Allan,Leonard R. Derogatis,Scott Durbin,Ashley Yacoubian,Deborah Wilkerson +6 more
TL;DR: A single treatment of RFc therapy was found to be safe and associated with both improved vaginal laxity and improved sexual function, and the results from this trial support the use of a novel non-surgical therapy for vagina laxity.
Journal ArticleDOI
Effect of Single-Session, Cryogen-Cooled Monopolar Radiofrequency Therapy on Sexual Function in Women with Vaginal Laxity: The VIVEVE I Trial.
Michael Krychman,Christopher G. Rowan,Bruce B Allan,Scott Durbin,Ashley Yacoubian,Deborah Wilkerson +5 more
TL;DR: This subanalysis showed CMRF therapy is associated with statistically significant and clinically important improvements in sexual function in women with vaginal laxity, and provides the first randomized, placebo-controlled energy-based device evidence for functional improvements associated with a nonsurgical modality for a highly prevalent and undertreated condition.